Product
ES014
2 clinical trials
4 indications
Indication
Advanced Solid TumorIndication
Solid TumorIndication
Locally Advanced Solid TumorIndication
Metastatic Solid TumorClinical trial
An Open-Label, Multicenter, First-in-Human, Dose Escalation and Expansion, Phase 1 Study of ES014 in Subjects With Locally Advanced or Metastatic Solid TumorsStatus: Withdrawn, Estimated PCD: 2026-04-30
Clinical trial
An Open-label, Multicenter, Dose-escalation and Cohort Expansion Phase 1 Clinical Study of ES014 Administered in Patients Locally Advanced or Metastatic Solid TumoursStatus: Recruiting, Estimated PCD: 2025-06-30